Jacquie Mahon
2020: The Future of Cutting-Edge Medicines is Now
United States: Regenerative Medicine The U.S. Food and Drug Administration (FDA) is currently reviewing more than 800 investigational new...
top of page
Search
Jacquie Mahon
- Apr 24, 2018
- 5 min
Subject-Matter Experts and Medical Writers: A Fruitful Alliance
I sighed inwardly as the Chief Medical Officer launched into another long story about the early days of the clinical research...
Jacquie Mahon
- Mar 2, 2018
- 3 min
The First of its Kind: An FDA-Approved Drug Label that Promises Delayed Incarceration
It seems many were flummoxed by the recent FDA approval of a label amendment for the established schizophrenia drug Invega Sustenna®. The...
Jacquie Mahon
- Feb 21, 2018
- 4 min
Right to Try and the FDA’s Expanded Access Program: No oversight? Or considered compassion.
"We need to fix this. But we do not need to undermine a working program that benefits patients by creating a deeply flawed alternative...
bottom of page